Alpine Associates Management Inc. purchased a new stake in shares of Advanced Accelerator Application SA (NASDAQ:AAAP) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 190,444 shares of the company’s stock, valued at approximately $15,545,000. Alpine Associates Management Inc. owned 0.43% of Advanced Accelerator Application at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Pentwater Capital Management LP lifted its position in Advanced Accelerator Application by 29.0% during the 4th quarter. Pentwater Capital Management LP now owns 80,000 shares of the company’s stock valued at $6,530,000 after acquiring an additional 18,000 shares during the period. California Public Employees Retirement System lifted its position in Advanced Accelerator Application by 493.3% during the 4th quarter. California Public Employees Retirement System now owns 48,589 shares of the company’s stock valued at $3,966,000 after acquiring an additional 40,400 shares during the period. Kassirer Asset Management Corp purchased a new position in Advanced Accelerator Application during the 4th quarter valued at about $1,632,000. Gamco Investors INC. ET AL purchased a new position in Advanced Accelerator Application during the 4th quarter valued at about $8,331,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. purchased a new position in Advanced Accelerator Application during the 4th quarter valued at about $16,737,000. 42.28% of the stock is owned by institutional investors.
AAAP has been the subject of a number of recent research reports. BidaskClub cut shares of Advanced Accelerator Application from a “sell” rating to a “strong sell” rating in a research report on Thursday, January 25th. Zacks Investment Research cut shares of Advanced Accelerator Application from a “buy” rating to a “hold” rating in a research report on Wednesday, November 22nd. JMP Securities cut shares of Advanced Accelerator Application from an “outperform” rating to a “market perform” rating in a research report on Monday, October 30th. JPMorgan Chase & Co. lowered shares of Advanced Accelerator Application from an “overweight” rating to a “neutral” rating and set a $82.00 price objective for the company. in a research note on Monday, November 20th. Finally, ValuEngine upgraded shares of Advanced Accelerator Application from a “sell” rating to a “hold” rating in a research note on Friday, February 2nd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $69.80.
Shares of Advanced Accelerator Application SA (NASDAQ:AAAP) opened at $81.63 on Wednesday. The firm has a market cap of $3,610.00 and a PE ratio of -50.70. Advanced Accelerator Application SA has a 12 month low of $35.11 and a 12 month high of $82.74.
Advanced Accelerator Application (NASDAQ:AAAP) last released its quarterly earnings data on Friday, November 17th. The company reported ($0.61) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.43). Advanced Accelerator Application had a negative net margin of 43.93% and a negative return on equity of 20.59%. equities analysts forecast that Advanced Accelerator Application SA will post -0.89 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/14/alpine-associates-management-inc-invests-15-55-million-in-advanced-accelerator-application-sa-aaap-stock.html.
About Advanced Accelerator Application
Advanced Accelerator Applications SA is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer.
Want to see what other hedge funds are holding AAAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Advanced Accelerator Application SA (NASDAQ:AAAP).
Receive News & Ratings for Advanced Accelerator Application Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Accelerator Application and related companies with MarketBeat.com's FREE daily email newsletter.